Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, Taiwan; International Center for Scientific Development of Shrimp Aquaculture, National Cheng Kung University, Tainan, Taiwan.
Division of Aquaculture, Fisheries Research Institute, Council of Agriculture, Keelung, Taiwan.
Fish Shellfish Immunol. 2023 Aug;139:108886. doi: 10.1016/j.fsi.2023.108886. Epub 2023 Jun 7.
To counter the recurrent outbreaks of bacterial (acute hepatopancreatic necrosis disease; AHPND) and viral (white spot disease; WSD) shrimp diseases, which still remain a threat to the global industry, shrimp gut microbiota research has been gaining more attention in recent years, and the use of probiotics in aquaculture has had promising results in improving shrimp gut health and immunity. In this review based on our studies on AHPND and WSD, we summarize our current understanding of the shrimp gastrointestinal tract and the role of the microbiota in disease, as well as effects of probiotics. We focus particularly on the concept of microbiota resilience, and consider strategies that can be used to restore shrimp gut health by probiotic intervention at a crucial time during gut microbiota dysbiosis. Based on the available scientific evidence, we argue that the use of probiotics potentially has an important role in controlling disease in shrimp aquaculture.
为了应对细菌性（急性肝胰腺坏死病；AHPND）和病毒性（白斑病；WSD）虾病的反复爆发，这些疾病仍然对全球产业构成威胁，近年来，虾肠道微生物组的研究受到了更多的关注，并且益生菌在水产养殖中的应用在改善虾肠道健康和免疫力方面取得了有希望的结果。在基于我们对 AHPND 和 WSD 的研究的综述中，我们总结了我们目前对虾胃肠道和微生物群在疾病中的作用以及益生菌的作用的理解。我们特别关注微生物组弹性的概念，并考虑在胃肠道微生物组失调的关键时期通过益生菌干预来恢复虾肠道健康的策略。根据现有科学证据，我们认为益生菌的使用在控制虾水产养殖中的疾病方面可能具有重要作用。
